Method of treating dry eye disorders
US7745461B1 · kind B1 · utility
4Cited by
25References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 26, 2007 |
| Grant date | Jun 29, 2010 |
| Priority date | — |
| Expiry date | Oct 20, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0048
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The topical use of EgLN-3 inhibitors is disclosed for the treatment of dry eye.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.